Sign in
8-K

Current Report

LEXICON PHARMACEUTICALS, INC. Filed Acc 0001062822-14-000002

Exit or restructuring costs · Executive or director change

  • Item 2.05 Costs associated with exit or disposal activities
  • Item 5.02 Departure or appointment of directors or officers

From the SEC's structured data for this filing

Loading form8-k01132014.htm…